Introduction
In superior canal dehiscence syndrome (SCDS), there is an abnormal opening in the bone over the superior semicircular canal [Minor et al., 1998 ]. This opening creates a third window into the inner ear, which may produce both vestibular and auditory signs and symptoms. Vestibular presentation may include vertigo and oscillopsia in response to sound and/or pressure changes (Tullio and/or Hennebert signs, respectively) and chronic disequilibrium. The auditory presentation may include autophony, bone-conductive hyperacusis and pulsatile tinnitus. Some patients may have a combination of both vestibular and auditory symptoms. The workup for SCDS includes physical examination, audiometric testing [Chien et al., 2007; Minor et al., 1998; Rosowski et al., 2004] , imaging by means of high-resolution computed tomography (CT) [Belden et al., 2003] and vestibular evoked myogenic potential (VEMP) testing [Brantberg et al., 1999] .
The VEMP is a measure of electromyographic (EMG) activity modulated by stimulating vestibular afferents with an acoustic stimulus. For the cervical VEMP (cVEMP), the response is a relaxation potential measured over the contracted ipsilateral sternocleidomastoid muscle. It is believed to originate from the saccule in response to air-conducted stimuli [Colebatch et al., 1994] . For the ocular VEMP (oVEMP), the response is an excitatory potential measured from the contralateral inferior oblique muscle [Rosengren et al., 2011] . Current evidence suggests that oVEMPs in response to midline forehead taps provide an assessment of the utricle [Iwasaki et al., 2007; Manzari et al., 2010b; Yang et al., 2010] . However, there is controversy about the origin of the oVEMP in response to air-conducted stimuli. Some investigations describe a primary utricular origin [Curthoys, 2010; Curthoys and Manzari, 2011; Manzari et al., 2010a] , while others argue that the response may include a small contribution from the saccule, thus originating from both utricle and saccule [Papathanasiou, 2012; Welgampola and Carey, 2010] .
In patients with SCDS, these VEMP responses are enhanced; the response amplitudes are larger and thresholds are reduced. The proposed hypothesis explaining these enhanced vestibular responses is that the labyrinth has reduced input impedance in the presence of a third mobile window [Rosowski et al., 2004] . Therefore, this VEMP enhancement is observed in both cVEMPs and oVEMPs. Brantberg et al. [1999] were the first to demonstrate that cVEMP thresholds were reduced in SCDS, and almost a decade later, the use of oVEMP testing was suggested for the diagnosis of SCDS [Rosengren et al., 2008] . More recent work has described that oVEMP recordings are more reliable than cVEMP recordings to separate SCDS patients from controls Manzari et al., 2012; Welgampola et al., 2008; Zuniga et al., 2013] .
Two studies on oVEMP measurements in surgically confirmed SCDS demonstrated that this test has excellent sensitivity and specificity Zuniga et al., 2013] . Hence, it is reasonable to anticipate a wider use of oVEMP testing for the future diagnosis of SCDS.
Recently, Piker et al. [2011] studied oVEMP responses in 10 healthy volunteers and found that the traditional standard electrode placement for the oVEMP recording ('montage 1'; fig. 1 a) could reduce the response amplitude. They suggest that some of the oVEMP activity might be detected by the reference electrode and therefore subtracted from the signal-averaged response measured at the active electrode. In other words, they suggest that montage 1 contaminates the oVEMP recording, and they propose an alternative to reduce this contamination by placing the reference electrode further from the active electrode (montage 2; fig. 1 b) . In their cohort, they observed that using montage 2 increased the oVEMP response by between 18 and 43% [Piker et al., 2011] .
The purpose of this study was twofold: first, to compare the sensitivity and specificity of oVEMP recordings using 2 electrode montages (montage 1 and montage 2) in patients with SCDS confirmed by high-resolution CT, and second, to investigate the percent change in oVEMP amplitude between these 2 electrode montages.
Methods

Subjects
Sixteen patients (mean age 49 years, range 24-76) with a diagnosis of SCDS and 12 age-matched healthy volunteers (mean age 48 years, range 24-76) with no prior history of neuro-otological complaints were enrolled in this study. The diagnosis of SCDS was based on a combination of at least 2 auditory or vestibular symptoms, at least 1 auditory or vestibular clinical sign (supported by audiometry and/or clinical examination) and high-resolution CT imaging ( table 1 ). Auditory and vestibular symptoms included au- . Audiometric clinical signs included the presence of conductive hyperacusis in the low frequencies (250-500 Hz) using extended bone conduction audiometry. High-resolution CT imaging demonstrating apparent dehiscence of the superior semicircular canal was a mandatory radiographic sign for diagnosis in all cases [Belden et al., 2003; Hirvonen et al., 2003] . In 10 of 17 cases, patients chose to have surgical repair of their dehiscence, providing direct evidence of a symptomatic dehiscence in these cases. Of note, 1 SCDS patient had previously undergone surgery for the repair of perilymphatic fistula in the same ear with the diagnosis of SCDS; another SCDS patient experienced symptoms bilaterally (both ears are included in the affected-SCDS group), and 6 patients had already undergone SCD surgical repair on the contralateral ear. Analyses and results are based on 3 ear groups: both ears of controls (n = 24), ears affected with SCDS (affected-SCDS; n = 17) and asymptomatic ears contralateral to SCDS (contralateral-SCDS; n = 15). Note that for the contralateral-SCDS ear group, we provided no distinction between the purely asymptomatic and the repaired ears because it has been described that surgical repair of ears with SCDS results in normalization of VEMP responses [Welgampola et al., 2008] .
oVEMP Recordings Calibrated TDH-49 headphones were used to deliver 500-Hz, 125-dB SPL tone bursts of positive polarity, with a linear envelope (1 ms rise/fall time, 2 ms plateau), at a repetition rate of 5 pulses/s. A total of 100 responses were averaged. EMG signals were amplified (2,500 μV) and band-pass filtered (3-500 Hz). Of note, 500-Hz tone bursts have been used in previous oVEMP testing investigations where an excellent segregation between controls and patients with SCDS was observed Welgampola et al., 2008; Zuniga et al., 2013] . oVEMP signals were recorded using 2 different electrode montages simultaneously. Montage 1 (standard) consisted of an active electrode placed approximately 5 mm below each eye, a reference electrode centered 2 cm below each active electrode and a ground electrode over the sternum ( fig. 1 a) . Montage 2 consisted of an active electrode placed approximately 5 mm below each eye, a single reference electrode placed on the chin and a ground electrode over the sternum ( fig. 1 b) .
Participants lay semirecumbent with their upper bodies elevated at a 30-degree angle from horizontal. Twenty-degree (+ and -) vertical saccades from the line of primary gaze orientation were performed to ensure that symmetrical signals were obtained from both eyes before recording oVEMP results, and if the signal change showed >25% asymmetry, the electrodes were replaced. When saccades could not be recorded, then the oVEMP test was considered 'nonrecordable' and was marked as a missing value. During oVEMP testing, participants were instructed to fix their gaze on a line on the ceiling that was located 30° up from their primary gaze orientation. For either montage, the N1 potential was identified as the first distinctive negative peak in the waveform occurring 7-11 ms after stimulus onset, and the P1 potential was identified as the first distinctive positive peak in the waveform occurring 12-16 ms after stimulus onset. The N1 amplitude was calculated as the amplitude from baseline to the peak of the N1 response, and the peakto-peak amplitude was calculated as the sum of the N1 and P1 amplitudes. Absent responses (no VEMP waveform despite proper eye movement recording with calibration) were considered as 
Statistical Analyses
Differences in oVEMP amplitudes between ear groups were analyzed using the Kruskal-Wallis test for each montage, followed by the Mann-Whitney U post hoc test for multiple comparisons, with a Bonferroni adjustment for the p value. Receiver-operating characteristic (ROC) curves were analyzed for each montage using as outcome parameters both the N1 and peak-to-peak amplitudes of controls and affected-SCDS ears, where an area of 1 represents a perfect test and an area of 0.5 represents a worthless test. The difference in oVEMP amplitude obtained with each montage was calculated as a change expressed in percentage: [(amplitude montage 2 -amplitude montage 1)/amplitude montage 1]. Differences in amplitudes between montages were analyzed for each ear group using the Wilcoxon signed rank test. Results were considered significant at the p < 0.05 level, except for those tests with an applied Bonferroni adjustment (p ≤ 0.017). Microsoft Excel 2007 (Seattle, Wash., USA) and IBM SPSS 21 (Chicago, Ill., USA) were used for statistical analyses.
Results
oVEMP responses were present in all control and SCDS ears using montage 1 (standard). Using montage 2, oVEMPs could not be recorded in 2 contralateral-SCDS ears and 1 control ear. Interestingly, these 2 contralateral-SCDS ears had facial hair. Due to these absent responses, the difference in oVEMP amplitudes between montages could not be calculated. Figure 2 depicts sample waveforms from the 3 different ear groups using montage 1 and montage 2.
Montage 1 versus Montage 2: Sensitivity and
Specificity oVEMP N1 amplitudes oVEMP recordings with montage 1 (standard) elicited significantly different N1 amplitudes across the 3 ear groups [H(2) = 34.7, p < 0.001]. Post hoc analysis indicated that oVEMP N1 amplitudes were significantly higher in affected-SCDS ears (median = 26.8 μV) compared to controls (median = 2.3 μV; U = 301.5, p < 0.001) and to contralateral-SCDS ears (median = 2.5 μV; U = 120, p < 0.001; fig. 3 ). There was no significant difference in N1 amplitudes between controls and contralateral-SCDS ears (U = 286, p = 0.686). ROC analysis revealed that the area under the curve was 0.996 (standard error 0.005). For this oVEMP recording, a cutoff value ≥ 13.1 μV showed excellent sensitivity (94%) and excellent specificity (95%).
Similarly, oVEMP recordings with montage 2 elicited significantly different N1 amplitudes across the 3 ear groups [H(2) = 32.3, p < 0.001]. Post hoc analysis indicated significantly higher N1 amplitudes in affected-SCDS ears (median = 34.4 μV) compared to both control (median = 3.85 μV; U = 257, p < 0.001) and to contralateral-SCDS ears (median = 3.5 μV; U = 93, p < 0.001; fig. 3 ). Again, there was no significant difference in N1 amplitudes between controls and contralateral-SCDS ears (U = 233, p = 0.720). ROC analysis revealed that the area under the curve was 0.990 (standard error 0.010). Thus, oVEMP recordings using montage 2 also provided excellent sensitivity (94%) and specificity (92%) using a cutoff value ≥ 12.75 μV.
oVEMP Peak-to-Peak Amplitudes For montage 1 (standard), peak-to-peak amplitudes were significantly different between affected-SCDS, control and contralateral-SCDS ears [H(2) = 34.9, p < 0.001]. Peak-to-peak amplitudes were significantly higher in the affected-SCDS ears (median = 66.6 μV) relative to control (median = 4.55 μV; U = 300, p < 0.001) and contralateral-SCDS ears (median = 4.8 μV; U = 120, p < 0.001). There was no significant difference between control and contralateral-SCDS ears (U = 293, p = 0.840; fig. 4 ). ROC analysis for montage 1 and oVEMP peak-to-peak amplitude showed an area under the curve of 1.0 (standard error <0.001). Thus, using a cutoff value of 24.5 μV or greater revealed excellent sensitivity (>99%) and specificity (>99%).
Peak-to-peak amplitudes recorded with montage 2 revealed significant differences between the 3 ear groups [H(2) = 33.12, p < 0.001]. Peak-to-peak amplitudes were significantly higher in affected-SCDS ears (median = 72.2 μV) than those of controls (median = 5.8 μV; U = 256, p < 0.001) and contralateral-SCDS ears (median = 7.7 μV; U = 91, p < 0.001). There was no significant difference between controls and contralateral-SCDS ears (U = 380.5, p = 0.597; fig. 4 ). ROC analysis for montage 2 and peak-to-peak amplitude showed an area under the curve of 1.0 (standard error <0.001), thus showed excellent sensitivity (>99%) and specificity (95%) with a cutoff value of ≥ 30.8 μV.
Montage 1 versus Montage 2: Differences in oVEMP Amplitude
In general, oVEMP N1 and peak-to-peak amplitudes with montage 2 were larger than those using montage 1 ( fig. 5 ). Both N1 (Z = -3.385, p = 0.001) and peak-to- peak amplitudes (Z = -3.29, p = 0.001) in the affected-SCDS ears and peak-to-peak amplitudes (Z = -2.529, p = 0.011) in the control group were significantly larger using montage 2. From montage 1 (standard) to montage 2 ( fig. 3-5 ), the median increase in oVEMP N1 amplitudes was 25% in control ears (range -100 to 380%; negative numbers represent a decrease in amplitude using montage 2), 27% in affected-SCDS ears (range -21 to 100%) and 18% in contralateral-SCDS ears (range -100 to 863%). Similarly, the median increase in oVEMP peak-to-peak amplitudes was 24% in control ears (range -100 to 122%), 23% in affected-SCDS ears (range -25 to 124%) and 26% in contralateral-SCDS ears (range -100 to 180%). Furthermore, the change in oVEMP N1 or peak-to-peak amplitudes using montage 1 versus montage 2 was not correlated with age across subjects (r = -0.076, p > 0.578) or with air-bone gaps -neither for low frequency (r = -0.208, p > 0.253) nor for largest air-bone gap in affected-SCDS ears (r = -0.081, p > 0.659; data not shown).
Discussion
The investigation conducted by Piker et al. [2011] suggests that oVEMP amplitudes recorded with montage 1 (standard) are contaminated by the close proximity of the reference electrode resulting in an approximate 30% amplitude reduction (range 18-43%). By placing the reference electrode further away from the active electrode (i.e. on the chin), the reference electrode was expected to capture minimal or no activity from the inferior oblique muscle, thus resulting in enhanced oVEMP amplitudes [Piker et al., 2011] . This opened up the question of whether oVEMP signals using montage 2 in patients with SCDS could result in even higher oVEMP amplitudes (e.g. >30% higher), making the segregation between controls and SCDS patients even clearer. In addition, SCDS is a vestibular entity with particular (high-amplitude) oVEMP responses that serves as a good model to study and support a vestibular origin for oVEMPs recorded with montage 2. Overall, results from the present investigation are in agreement with the findings of Piker et al. [2011] in that oVEMP amplitudes showed a median increase of 18-26% between groups by adopting this innovative electrode placement (montage 2). This trend is similar to the 30% mean increase described by Piker et al. [2011] . We demonstrated a statistically significant increase in oVEMP amplitudes from montage 1 to montage 2 for affected-SCDS ears (both N1 and peak-to-peak amplitude) and control ears (peak-to-peak amplitude). However, a large degree of variability was observed in our cohort (-100 to 863%) with some ears (n = 13; normal controls: n = 8, affected-SCDS ears: n = 2; contralateral-SCDS ears: n = 3) demonstrating a decrease from montage 1 to montage 2 compared to the cohort of Piker et al. [2011] where all subjects demonstrated an increase in oVEMP amplitude (range 18-43%). This greater variability was more evident in ears that tended to have regular and smaller size oVEMP waveforms (controls and contralateral-SCDS ears). Three subjects had no response to montage 2, yielding a -100% difference between montages. In 2 contralateral-SCDS ears, this absent response may be attributed to facial hair, which would preclude the reference electrode from detecting and cancelling out common noise. We speculate that neighboring EMG activity may play a role in montage 2. While oVEMP recordings with montage 2 have the advantage of a 'less subtracting effect' by the reference electrode being further away from the inferior oblique muscle, this 'extra' separation also renders more susceptibility to neighboring EMG activity, such as activity coming from orbicularis oris, masseter or other facial muscles. Our primarily enhanced responses with montage 2 sug- gest this montage provides better noise cancellation; however, the large variability raises speculation about the contribution of surrounding muscles. Because vestibular-related muscle potential changes can occur in a variety of muscles throughout the body, it is difficult to determine whether tension or relaxation of these surrounding muscles potentially results in a noisier and/or altered recording in addition to better noise cancellation. Interfering activity from these surrounding muscles might explain the absent oVEMP responses with montage 2, despite having good calibration and present oVEMP responses using montage 1, and might also explain our increased variability compared to those of Piker et al. [2011] . Despite our similar methodology, our subjects were only instructed to maintain and upgaze during recordings, but no further explanation or restrictions were given regarding avoiding to clench their jaw or do any other facial movements. Finally, based on our analyses, we do not suspect that age or air-bone gap contributed to this finding. The excellent sensitivity and specificity of oVEMP amplitudes (both N1 and peak-to-peak) in this study, regardless of electrode montage, corroborate that oVEMP amplitude measurement is an excellent test in the diagnosis of SCDS. These results are in agreement with prior work conducted by our group which has shown excellent sensitivity and specificity (>90%) for oVEMP amplitudes in surgically confirmed SCDS patients Zuniga et al., 2013] . However, while amplitudes did increase with montage 2, the sensitivity and specificity of using oVEMP amplitudes to discriminate between normal controls and patients with SCDS did not improve significantly. For the purpose of supporting the diagnosis of SCDS, results from this investigation did not find significant benefits of switching from recording oVEMPs using the standard electrode placement (montage 1) to the novel electrode placement (montage 2). In fact, considering the greater variability observed with montage 2 in addition to the limitation of nonrecordable oVEMPs in the presence of facial hair, montage 1 can be more reliable.
It may be that use of electrode montage 2 will demonstrate benefit in the diagnosis of other inner ear conditions. For example, in individuals with naturally smaller oVEMP amplitudes, like older subjects or patients with Ménière's disease, recordings with electrode montage 2 could increase the likelihood of yielding present responses and help better appreciate small versus absent responses. However, further investigation is needed to validate this electrode montage as being purely vestibular in origin and to rule out the effects of other facial muscles.
Conclusion
Our findings suggest that oVEMP recordings with the standard electrode montage (montage 1) remain a reliable method for the evaluation of SCDS. Specifically, oVEMP peak-to-peak amplitudes utilizing the standard electrode montage provide excellent sensitivity and specificity.
